Get to know our clinical trials
Mayor respuesta a la Terapia de Resincronización Cardiaca (TRC) con Estimulación Multisitio
THE PURPOSE OF THIS STUDY IS TO DEMONSTRATE THAT ACTIVATION OF MULTIPOINT PACING (MPP) INCREASES THE RESPONSE RATE TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WHO HAD NOT RESPONDED TO THIS THERAPY (NONRESPONDERS) AFTER 6 MONTHS OF FOLLOW-UP. THIS IS A SUMMARY OF THE CLINICAL TRIAL. ONCE YOU CONTACT US, WE WILL PROVIDE YOU WITH ALL THE INFORMATION YOU NEED.
Technical Summary
- INCREASED RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY (CRT) WITH MULTISITE PACING
- Code EudraCT: -
- Protocol number: CR-13-006-ID-HF
- Promoter: St. Jude Medical España, S.A.
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Who can participate?
Patients must meet current Class I or IIa indications for CRT implantation according to ESC or ACCF/AHA/HRS guidelines (including single-chamber or dual-chamber ICD upgrades).
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.